If this will be confirmed in future studies, tumors cells expressing MHC class II molecules not only act as APC for priming naïve tumor-specific CD4+ T cells but also perform APC activity ectopically with respect to the canonical site represented by the lymph nodes. This evidence concerns the gene CD4 and neoplasm.